Future research also needs to explore potential differences according to patient clinical characteristics, type of GLP-1 RA compound, as well as time, method, and dosage of GLP-1 RA administration
(2023) Effects of onceweekly semaglutide on appetite, energy intake, control of eating, food preference, and body weight in subjects with obesity, Diabetes, Obesity, and Metabolism (2017) Insulin resistance/hyperinsulinemia: An important cardiovascular risk factor that has long been underestimated, Frontiers in Cardiovascular Medicine (2024) American Heart Association recommendations for physical activity in adults and kids, American Heart Association (2024) The role of the thyroid in polycystic ovary syndrome, Frontiers in Endocrinology (2023) When your weight gain is caused by medicine, University of Rochester Medical Center (2024) Stress, cortisol, and other appetite-related hormones: Prospective prediction of 6-month changes in food cravings and weight, Obesity (2017) Causal association between obesity and hypothyroidism: a two-sample bidirectional Mendelian randomization study, Frontiers in Endocrinology (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
The search was limited to outcome trials evaluating the efficacy of DPP-4 inhibitors, GLP-1RA and SGLT-2 inhibitors on cardiovascular, heart failure or renal outcomes in adult patients with or without type 2 diabetes
it signals local repair processes
Support how your body processes and burns fat particularly stubborn visceral abdominal fat
In the study by Jensen et al
